Therefore, although it was recently reported that PPARγ agonists possess anti-inflammatory activity, PPARα agonists may also have a role in immunity and inflammation in CRSsNP, as reported in other systems [43]. The gene discussed is PPARG; the disease is chronic rhinosinusitis without nasal polyps.